EASO

The European Association for the Study of Obesity represents 40 European nations dedicated to understanding and addressing obesity to improve public health.

[EASO @EASOobesity]

📢The EASO Algorithm for the pharmacological treatment of obesity and its complications has been published in @NatureMedicine

Developed using rigorous analysis, it provides clinically relevant guidance for personalised medication management. https://t.co/SLb8bIRyZW
@busetto_luca

[EASO @EASOobesity]

Sarcopenic Obesity and Obesity in Older Adults - SO3A, Working Group forms a network of European and international experts, working in clinical management and research.

Watch the video and learn more from Co-chairs Lorenzo Donini and Mette Svendsen. ➡️ https://t.co/AIG0tzfCfU

[EASO @EASOobesity]

Abstracts of #ECO2026 Plenary Lectures, EASO Sessions, Joint and Topic Sessions and more in Obesity Facts:

https://t.co/rrjOVjdi4w

@EASOPresident @KargerPublisher

[EASO @EASOobesity]

ECN Spotlight: Meet Pablo Jiménez López - from the University of Almería.

Find out what excites Pablo the most about the future of obesity research and initiatives he is most interested in collaborating on with other ECN members.

Read more: https://t.co/x3CcDApXEu

[EASO @EASOobesity]

Obesity causes type 2 diabetes via a physiological fat-glucose homeostatic circuit HT @DanielJDrucker @Cell_Metabolism

[Daniel J Drucker @DanielJDrucker]

A physiological homeostatic circuit through which obesity causes type 2 diabetes and #insulin resistance @Cell_Metabolism https://t.co/LVsLZiNQI3

[SEEDO @SociedadSeedo]

🧬 IV Jornada del Grupo de Dietética SEEDO

El próximo 18 de septiembre, el Hospital Universitario Infanta Sofía acogerá la jornada “Abordaje integral de la obesidad: del código epigenético al cambio real del paciente”.

Un encuentro para profundizar en la relación entre epigenética, nutrición y transformación del paciente, desde una visión multidisciplinar y con la participación de profesionales sanitarios de diferentes ámbitos.

📍 Salón de Actos del Hospital Universitario Infanta Sofía @SaludMadrid
Consulta el programa provisional e inscríbete: https://t.co/rPk3o6TLzU

#SEEDO #Obesidad #Nutrición #Dietética #Epigenética #Salud #FormaciónSanitaria

[EASO @EASOobesity]

@EASLnews, EASO and @EASDnews have issued new clinical practice guidelines on mgmt for people living with MASLD.

@FrancqueSven shares strategies to adopt them in your clinic.

5-minute CPD ➡️ What are the key approaches?

https://t.co/tF5j5D9qpV

[EASO @EASOobesity]

EASO joins WOF in congratulating Prof María del Mar Malagón! @MardelMala

The Wertheimer Award recognises outstanding contributions to basic obesity research, celebrating scientific excellence that advances our understanding of obesity biology and helps shape future prevention and treatment. 👏👏

[EASO @EASOobesity]

Join the 11th UK Congress on Obesity (UKCO) in Sheffield 🇬🇧 on 17-18 September 2026.

The UKCO 2026 brings together the latest scientific research, policy and patient perspectives on current issues.

Learn more: https://t.co/D4Z2J24NKD

[Scott Isaacs @scottisaacsmd]

Mood risk with GLP-1RAs appears clinically reassuring during active treatment, neutral versus DPP-4 inhibitors and lower than SGLT2 inhibitors, but increases after discontinuation, with anxiety as the predominant signal. For patients with existing or high risk of anxiety disorders, treat cessation as a vulnerable period and consider tapering, structured follow up, and proactive mental health support when transitioning off GLP therapy.
https://t.co/QA4Li4v2EC

[EASO @EASOobesity]

Nick Finer discusses new research suggesting that lift capacity and safety signs based on the maximum number of people permitted may be out of date as average body weights rise.

Watch here: https://t.co/HsydwotiRZ

#ECO2026

[EASO @EASOobesity]

Meet the winners of the #ECO2026 Prize for Advocacy, Impact & Innovation and Prize for Public Engagement & Science Communication

🌟 Nour Baratli
🌟 Pablo Jiménez López

Learn more about the prizes and the winners: https://t.co/tXpFbz3q6L

[EASO @EASOobesity]

🌟 EASO Publication Spotlight

The updated EASO framework helps clinicians match pharmacological obesity management to an individual’s health needs, moving beyond weight loss alone to consider complications, mechanisms and treatment goals.

https://t.co/289FP5r93D

#ECO2026

[EASO @EASOobesity]

In September 2026, colleagues from across Poland 🇵🇱 and the international paediatric endocrinology community will gather in Katowice to celebrate an important milestone in European child health.

Learn more and register: https://t.co/FdQvZxBlnk

[EASO @EASOobesity]

ECN eLearning Hub webinar: Unpacking Ultra-Processed Food with Dr Zoé Colombet, Dr Yanaina Chavez-Ugalde and @EmmaBoyland

➡️ Key insights into the growing evidence base on ultra-processed foods and their significance for public health.

Watch here: https://t.co/6prxoRQcZO

[EASO @EASOobesity]

Obesity Assessment: Practical tips for Clinical Evaluation of Obesity

Learn more from Dr Jean O’Connell, MD, PhD - St Columcille's and St Vincent's University Hospital's Centre for Obesity Management, Ireland

https://t.co/nIOHSP2kWH

[World Obesity @WorldObesity]

🧬 Wertheimer Award

Congratulations to Prof María del Mar Malagón!

The Wertheimer Award recognises outstanding contributions to basic obesity research, celebrating scientific excellence that advances our understanding of obesity biology and helps shape future prevention and treatment.

👏 #ICO2026

[World Obesity @WorldObesity]

🩺 Willendorf Award

Congratulations to Prof Antje Körner!

The Willendorf Award recognises outstanding clinically oriented obesity research and honours those whose work is improving obesity care and outcomes for people living with obesity around the world.

👏 #ICO2026

[EASO @EASOobesity]

The EASO Physical Activity Fitness and Function Working Group provides a platform to explore and share knowledge on physical activity and fitness, and how these affect participation and function for people living with obesity.

Learn more: https://t.co/LKGds37Ckq

[EASO @EASOobesity]

Treating obesity can improve health outcomes including MASLD. @DrPietilainen shares evidence-based strategies you can use to support patients living with obesity and MASLD.

Join our new 5-minute continuing Professional Development Programme 👇

https://t.co/9vzWHgHPzM